生物活性 | |||
---|---|---|---|
描述 | SPHINX is a specific inhibitor of SRPK1, demonstrating an IC50 value of 0.58 μM. It significantly diminishes Choroidal Neovascularization (CNV) in vivo. SPHINX holds promise for investigating age-related macular degeneration (AMD) [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.82mL 0.56mL 0.28mL |
14.11mL 2.82mL 1.41mL |
28.22mL 5.64mL 2.82mL |
参考文献 |
---|